Indaptus Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
15 nov. 2021 07h00 HE
|
Indaptus Therapeutics
NEW YORK, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company”), today announces financial results for the third quarter ended September 30, 2021...
Indaptus Therapeutics Receives Notice of Allowance for Strategic Patent
15 sept. 2021 07h00 HE
|
Indaptus Therapeutics
NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company”), today announced that the United States Patent and Trademark Office has issued a...